Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children

September 8, 2025 updated by: AO Innovation Translation Center

PedORTHO-A Prospective Multicenter Observational Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children

International registry to collect prospective treatment and outcomes data on specific, key non-pathological fractures in children with open physes. Data will be collected during follow-up visits according to standard of care at 3 to 8 weeks, 3, 6, 12 and 24 months

Study Overview

Detailed Description

This international registry will collect prospective treatment and outcomes data on specific, key non-pathological fractures in children with open physes. The long-term goal is to build this registry to include all fractures according to the AO pediatric fracture classification (AO PCCF). However, to establish proof-of-principle and study feasibility, the investigators aim to first begin with the inclusion of a limited number of key long bone fracture types for which optimal treatment and management are under particular debate, or for which substantial clinical equipoise exists. Consequently, the investigators aim to begin with separate registry arms based on defined fracture segments in specific bones. Each registry arm will be defined by a customized set of outcomes to be collected. Participants will be enrolled into these specific arms according to their injury diagnosis. The registry arms will be categorized as follows:

  • Proximal humerus fractures
  • Distal humerus fractures
  • Proximal radius fractures
  • Forearm shaft fractures
  • Tibial shaft fractures (with/without fibula fracture)

All participants enrolled in the registry will be followed over the course of their treatment from the time of enrolment to end of treatment in accordance with the treating surgeon's regular clinical practice. All relevant information will be recorded at baseline and at each follow-up visit that participants attend at the orthopedic clinic, according to standard of care for each fracture type. A standardized set of prospective data including demographic information, baseline injury information, diagnosis, treatment details and clinical, radiographic, functional, and PROs will be collected for each participant. Data involving additional outcomes or variables may also be collected depending on the specific sub-study or registry arm that the participant is enrolled in.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sydney, Australia
        • The Children's Hospital at Westmead
    • Queensland
      • Brisbane, Queensland, Australia, 4101
        • Queensland CHILDREN'S HOSPITAL
      • Halifax, Canada
        • IWK Health Centre
      • Ottawa, Canada
        • Children's Hospital of Eastern Ontario (CHEO)
      • Toronto, Canada
        • The Hospital for Sick Children
      • Vancouver, Canada
        • BC Children's Hospital
      • Valdivia, Chile
        • Hospital Base Valdivia
      • Rijeka, Croatia
        • Clinical Hospital Centre Rijeka
      • Karlsruhe, Germany
        • Kinderchirurgische Klinik, Klinikum Karlsruhe
      • Tamale, Ghana
        • Tamale Teaching Hospital
      • Pátrai, Greece
        • Karamandaneio Children's Hospital
      • Mangalore, India
        • Tejasvini Hospital and Shantharam Shetty Institute of Orthopaedics and Traumatology (SSIOT) (Orthopaedics)
      • Peshawar, Pakistan
        • Lady Reading Hospital
      • Barcelona, Spain
        • Hospital Sant Joan de Deu Barcelona
      • Valladolid, Spain
        • Hospital Universitario del Río Hortega
    • Missouri
      • Columbia, Missouri, United States, 65212
        • University of Missouri Health Care
      • Caracas, Venezuela
        • Hospital Universitario de Caracas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Consecutive pediatric patients with key long bone fractures.

Description

Inclusion Criteria:

  • Radiologically confirmed open physis in the injured bone at time of injury
  • Diagnosis of an isolated fracture according to the AO PCCF
  • Willingness and ability of the patient/parents/legally responsible care giver to participate in the registry, including obtaining imaging and adhering to follow-up procedures according to standard of care in each clinic
  • Willingness and ability of the parent(s) to support the patient in his/her study participation
  • Ability of parents or a legal guardian to understand the content of the patient information/ICF and to sign and date the IRB/EC approved written informed consent form

Exclusion Criteria:

  • Radiologically confirmed closed physis in the injured bone at time of injury
  • Polytrauma/multiple fractures
  • Previous fracture of the same anatomical region
  • Underlying musculoskeletal or neuromuscular disorder
  • Present to participating centers with a displaced humeral fracture, tibial shaft fracture, forearm fracture, or femoral neck fracture at greater than 4 weeks postinjury
  • Unable to provide the legal consent
  • Inability of the patient/parents/legally responsible caregiver to participate in imaging and/or FU procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Data collection of fracture and trauma details
Time Frame: up to 24 months
To analyze the AO Pediatric Long Bone Fracture Classification in terms of utility for treatment decision-making and prediction of fracture outcomes
up to 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Axial deviation and range of motion (ROM)
Time Frame: up to 24 months
Axial deviation or difference in ROM in the shoulder (abduction/adduction, internal rotation/external rotation, flexion/extension), elbow (flexion/extension, varus/valgus), wrist (flexion/extension, abduction/adduction, supination/pronation), hip (flexion/extension, abduction/adduction, internal rotation/external rotation (in flexion)), knee (flexion/extension), ankle (flexion/extension, supination/pronation, abduction/adduction)
up to 24 months
Leg length discrepancy
Time Frame: up to 24 months
The Leg Length Discrepancy (LLD) will be measured using the standing blocks method
up to 24 months
Return to full activity
Time Frame: up to 24 months
Time to full weight-bearing, time to full activity, and time to return to kindergarten/school
up to 24 months
Implant removal
Time Frame: up to 24 months
Assessment if implant removal was done.
up to 24 months
Patient-reported outcome
Time Frame: up to 24 months
Patient Reported Outcomes of Fracture Healing
up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kishore Mulpuri, Prof, BC Children's Hospital, Vancouver
  • Principal Investigator: Emily Schaeffer, Dr, BC Children's Hospital, Vancouver
  • Principal Investigator: Alexander Joeris, Prof, AO foundation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2022

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

December 19, 2019

First Submitted That Met QC Criteria

December 19, 2019

First Posted (Actual)

December 23, 2019

Study Record Updates

Last Update Posted (Estimated)

September 12, 2025

Last Update Submitted That Met QC Criteria

September 8, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PedORTHO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Long Bone Fractures

Clinical Trials on Conservative (non-surgical) treatment

Subscribe